Our team of editors discuss what they think about the current Next Generation Healthcare issues
Guus Simons of PathoFinder reveals where the molecular diagnostics sector in Europe is heading.
Why it is important to consider all potential pathogens, even during the novel Influenza A H1N1 pandemic. By Rob Janssen, Sales and Marketing Manager of PathoFinder
As molecular diagnostics expands in the clinical setting, diagnostic laboratories face the challenge of achieving dependable, convenient, and affordable quality control. AcroMetrix offers an effective solution through independent, external quality control materials.